Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country's drug regulator announced the company had pulled its proposal seeking an accelerated approval for local trials.
India had, in May, scrapped local trials for "well-established" foreign coronavirus vaccines as it tried to hasten vaccination rollouts to fight a second wave of infections.
"We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver our COVID-19 vaccine to India," Johnson & Johnson said in an emailed statement.
The Indian
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)